NCT07581808 Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention Status NOT_YET_RECRUITING Phase PHASE4
NCT07102628 Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes Status RECRUITING Phase PHASE3
NCT06858332 Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia Status RECRUITING Phase N/A
NCT06813911 Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD Status RECRUITING Phase PHASE3
NCT06597019 Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia Status RECRUITING Phase PHASE3
NCT06597006 Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia Status RECRUITING Phase PHASE3
NCT06586684 Effect of Small Interfering RNA Inclisiran on Carotid Plaques As Assessed by Carotid Ultrasound Status NOT_YET_RECRUITING Phase PHASE4
NCT06421363 Continuity of Care Between Primary Care Cardiology and Specialty Services for Patients With Chronic Ischemic Heart Disease Status NOT_YET_RECRUITING Phase PHASE4
NCT06386419 A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia Status COMPLETED Phase PHASE4
NCT06372925 Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction Status RECRUITING Phase PHASE4
NCT06287177 Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy Status RECRUITING Phase N/A
NCT06249165 VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05888103 Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol. Status COMPLETED Phase PHASE3
NCT05763875 Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy. Status COMPLETED Phase PHASE3
NCT05682378 Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies Status RECRUITING Phase PHASE3
NCT05639218 Impact of Optimal Pharmacotherapy on Lipid Profile and Qualitative Features of Atherosclerotic Plaques Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05004675 Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients Status COMPLETED Phase PHASE3
NCT04929249 A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) Status COMPLETED Phase PHASE3
NCT04873934 Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome Status COMPLETED Phase PHASE3